Cold atmospheric plasma‐mediated tumor microenvironment remodeling for cancer treatment
BMEMat · 2026-06 · 4 (2)
DOI: 10.1002/bmm2.70041 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMEMat, online erschienen am 27.11.2025. Verfasst von Israr Khan und 8 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 427 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Shenzhen Graduate School, Peking University, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Cancer is still a serious clinical concern, and current therapy is ineffective due to the complex tumor microenvironment (TME). Thus, TME targeting has gained recognition as a significant therapeutic target in cancer therapy. Among these, cold atmospheric plasma (CAP) has been proposed as an emerging and novel cancer treatment owing to its unique characteristics of non‐invasive nature and selective tumor cell killing. The current investigation reveals CAP as an effective strategy for TME modulation and tumor eradication, emphasizing its potential to enhance antitumor responses. This review explores the therapeutic potential of CAP in cancer treatment, with a particular focus on its impact on the TME and the underlying mechanisms of tumor cell death. Initially, the review provides a comprehensive overview of the TME and underscores its critical role in cancer progression and treatment responsiveness. It then examines the efficacy of CAP across various in vitro and in vivo tumor models, highlighting its modulatory effects on key components of the TME, including immune cells, stromal cells, and cancer physiological hallmarks such as immune suppression, hypoxia, acidosis, angiogenesis, and metabolism. Furthermore, the review synthesizes evidence on the diverse mechanisms of CAP‐induced tumor cell death, including apoptosis, pyroptosis, ferroptosis, autophagy, and necrosis. Together, findings from a wide range of experimental studies demonstrate the promise of CAP as a selective and safe antitumor agent, capable of reprogramming the TME and inducing numerous forms of cancer cell death. In addition, the review addresses current challenges and future directions for CAP and stresses the necessity of protocol standardization, large‐scale experimental validation, and rigorous safety evaluation before clinical implementation. Finally, the review anticipates CAP as a revolutionary tool in cancer care, offering hope for improved therapeutic efficacy and a paradigm shift in cancer treatment.
Förderung
- National Key Research and Development Program of China
- Shenzhen Graduate School, Peking University
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Khan, I., Fang, Q., Fei, C., Wang, Z., Chen, Z., Chen, G., Xu, Z., Xu, S., & Chen, Z. (2026). Cold atmospheric plasma‐mediated tumor microenvironment remodeling for cancer treatment. BMEMat, 4(2). https://doi.org/10.1002/bmm2.70041
Vancouver
Khan I, Fang Q, Fei C, Wang Z, Chen Z, Chen G, et al. Cold atmospheric plasma‐mediated tumor microenvironment remodeling for cancer treatment. BMEMat. 2026;4(2). doi:10.1002/bmm2.70041
BibTeX
@article{Khan2026,
author = {Khan, Israr and Fang, Qiujie and Fei, Cao and Wang, Ziyuan and Chen, Zhaowei and Chen, Guojun and Xu, Zhiming and Xu, Shu and Chen, Zhitong},
title = {Cold atmospheric plasma‐mediated tumor microenvironment remodeling for cancer treatment},
journal = {BMEMat},
year = {2026},
volume = {4},
number = {2},
doi = {10.1002/bmm2.70041}
}
EUVIMED